| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Common Stock | Award | $5,921,593 | +6,815 | +53% | $868.88 | 19,719 | 10 Feb 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Restricted Stock Unit | Award | $0 | +3,752 | $0.000000 | 3,752 | 10 Feb 2025 | Common Stock | 3,752 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |